Analyst Price Target is $16.37
▲ +122.40% Upside Potential
This price target is based on 19 analysts offering 12 month price targets for GoodRx in the last 3 months. The average price target is $16.37, with a high forecast of $47.00 and a low forecast of $6.00. The average price target represents a 122.40% upside from the last price of $7.36.
Current Consensus is
The current consensus among 19 contributing investment analysts is to hold stock in GoodRx.
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was incorporated in 2015 and is headquartered in Santa Monica, California.